Division of Cardiovascular Medicine, Henry Ford Health System, Detroit, Michigan (Drs Keteyian and Brawner); Centers for Disease Control and Prevention, Atlanta, Georgia (Drs Jackson, Ritchey, and Sperling, Mr Chang, and Ms Wall); Department of Public Health Sciences, Henry Ford Health System, Detroit, Michigan (Dr Brawner); Divisions of Geriatrics and Cardiology, University of Pittsburgh and the VA Pittsburgh GRECC, Pittsburgh, Pennsylvania (Dr Forman); Division of Cardiovascular Diseases, University of Michigan, Ann Arbor (Dr Sukul); and Center for Heart Disease Prevention, Emory University School of Medicine, Atlanta, Georgia (Dr Sperling).
J Cardiopulm Rehabil Prev. 2022 Jul 1;42(4):235-245. doi: 10.1097/HCR.0000000000000675. Epub 2022 Feb 8.
PURPOSE: This study updates cardiac rehabilitation (CR) utilization data in a cohort of Medicare beneficiaries hospitalized for CR-eligible events in 2017, including stratification by select patient demographics and state of residence. METHODS: We identified Medicare fee-for-service beneficiaries who experienced a CR-eligible event and assessed their CR participation (≥1 CR sessions in 365 d), engagement, and completion (≥36 sessions) rates through September 7, 2019. Measures were assessed overall, by beneficiary characteristics and state of residence, and by primary (myocardial infarction; coronary artery bypass surgery; heart valve repair/replacement; percutaneous coronary intervention; or heart/heart-lung transplant) and secondary (angina; heart failure) qualifying event type. RESULTS: In 2017, 412 080 Medicare beneficiaries had a primary CR-eligible event and 28.6% completed ≥1 session of CR within 365 d after discharge from a qualifying event. Among beneficiaries who completed ≥1 CR session, the mean total number of sessions was 25 ± 12 and 27.6% completed ≥36 sessions. Nebraska had the highest enrollment rate (56.1%), with four other states also achieving an enrollment rate >50% and 23 states falling below the overall rate for the United States. CONCLUSIONS: The absolute enrollment, engagement, and program completion rates remain low among Medicare beneficiaries, indicating that many patients did not benefit or fully benefit from a class I guideline-recommended therapy. Additional research and continued widespread adoption of successful enrollment and engagement initiatives are needed, especially among identified populations.
目的:本研究更新了医疗保险受益人群中 2017 年符合心脏康复(CR)条件的事件住院患者队列中的 CR 利用率数据,包括按选定患者人口统计学特征和居住州进行分层。
方法:我们确定了经历过 CR 合格事件的医疗保险收费服务受益人群,并通过 2019 年 9 月 7 日评估了他们的 CR 参与(365 天内至少进行 1 次 CR 治疗)、参与度和完成度(≥36 次)率。评估指标包括总体、按受益人群特征和居住州以及按主要(心肌梗死;冠状动脉旁路移植术;心脏瓣膜修复/置换;经皮冠状动脉介入治疗;或心肺移植)和次要(心绞痛;心力衰竭)合格事件类型进行评估。
结果:2017 年,412080 名医疗保险受益人群发生了主要的 CR 合格事件,其中 28.6%的人在出院后 365 天内完成了至少 1 次 CR 治疗。在完成至少 1 次 CR 治疗的受益人群中,平均总治疗次数为 25±12,27.6%的人完成了≥36 次治疗。内布拉斯加州的入组率最高(56.1%),其他四个州的入组率也超过 50%,而 23 个州的入组率低于美国的总体水平。
结论:医疗保险受益人群中的绝对入组率、参与度和方案完成率仍然较低,这表明许多患者没有从 I 类指南推荐的治疗中获益或未完全获益。需要进一步研究并持续广泛采用成功的入组和参与计划,特别是针对确定的人群。
J Cardiopulm Rehabil Prev. 2022-7-1
Circ Cardiovasc Qual Outcomes. 2020-1
Am Heart J. 2025-4
J Am Geriatr Soc. 2025-6
Am Heart J. 2025-4
J Am Heart Assoc. 2024-12-17
J Am Coll Cardiol. 2021-3-23
J Cardiopulm Rehabil Prev. 2021-3-1
Circ Cardiovasc Qual Outcomes. 2021-2
J Cardiopulm Rehabil Prev. 2021-9-1
J Cardiopulm Rehabil Prev. 2021-1-1
J Cardiopulm Rehabil Prev. 2020-9
Arch Phys Med Rehabil. 2020-6-27